Fox NewsHealth
Test may show which men need aggressive prostate cancer care
A genomic test called Decipher may help doctors identify high-risk prostate cancer patients who are more likely to benefit from abiraterone hormone therapy. Others may be able to avoid the treatment, potentially reducing unnecessary medication and side effects.
This card is an AI-assisted summary of reporting published by Fox News. Read the original report before relying on it for medical, legal, financial, safety, or emergency decisions.